Issued Patents 2022
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530214 | Bicyclic heterocycles as FGFR inhibitors | Liang Lu, Wenqing Yao, Fenglei Zhang | 2022-12-20 |
| 11459329 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Liangxing Wu, Wenqing Yao | 2022-10-04 |
| 11433071 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei +4 more | 2022-09-06 |
| 11401272 | Heterocyclic compounds as LSD1 inhibitors | Zhenwu Li, Liangxing Wu, Wenqing Yao, Fenglei Zhang | 2022-08-02 |
| 11261191 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Colin Zhang, Ding-Quan Qian, David M. Burns +3 more | 2022-03-01 |
| 11247992 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Xiaozhao Wang, Wenqing Yao, Fenglei Zhang | 2022-02-15 |
| 11220510 | Pyrrole tricyclic compounds as A2A / A2B inhibitors | Xiaozhao Wang, Peter Carlsen, Taisheng Huang | 2022-01-11 |